During the past decade, convincing evidence has accumulated that conquering heart disease is not simply a matter of driving serum cholesterol down. In fact, one half of the people who have a heart attack have normal cholesterol and now low cholesterol is being associated with a significant risk of early cognitive decline. New information is avaialable. Clinicians are no longer limited to using antiquated measures of cholesterol, blood pressure, and blood sugars as the primary markers of increased risk for cardiometabolic disorders: advanced lipid assays, markers of oxidative stress, inflammation, hormone, and body composition are all providing new opportunities for safer and more effective early interventions to prevent and reverse cardiometabolic disease.
This module is now offered as a 60-day online cohort course. Following a semi-synchronous format, learners can review lectures at their own pace. Learners will have access to a private discussion forum to network with colleagues and further their understanding of the course materials with the support of IFM facilitators and educators.
